Literature DB >> 7074110

Calcium-dependent aggregation of human serum amyloid P component.

M L Baltz, F C De Beer, A Feinstein, M B Pepys.   

Abstract

Normal human serum or isolated human amyloid P component was ultracentrifuged on density gradients containing either 10 mM EDTA or different concentrations of Ca2+ between 0.15 and 2.15 mM. In the presence of Ca2+ concentrations of 1 mM or more human P component sedimented more rapidly than it did in the presence of lower Ca2+ levels or of EDTA. This phenomenon was due to Ca2+-dependent aggregation of P component molecules and did not require the presence of any other serum constituents. It was completely inhibited by incorporating a physiological concentration (40 mg/ml) of serum albumin in the gradients, suggesting that free ionized Ca2+ is required to promote aggregation of the P component. P component from the mouse and the plaice (Pleuronectes platessa L.), a marine teleost, did not undergo the same Ca2+-dependent aggregation as human P component. These observations resolve a discrepancy existing in the literature concerning the sedimentation rate of human P component in density gradient ultracentrifugation and shed new light on its behaviour with respect to Ca2+ which may be relevant to the deposition of P component in amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074110     DOI: 10.1016/0167-4838(82)90118-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques.

Authors:  Chiara Mencarelli; Gerard H Bode; Mario Losen; Mahesh Kulharia; Peter C Molenaar; Robert Veerhuis; Harry W M Steinbusch; Marc H De Baets; Gerry A F Nicolaes; Pilar Martinez-Martinez
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

2.  Antibody-array interaction mapping, a new method to detect protein complexes applied to the discovery and study of serum amyloid P interactions with kininogen in human plasma.

Authors:  Derek Bergsma; Songming Chen; John Buchweitz; Robert Gerszten; Brian B Haab
Journal:  Mol Cell Proteomics       Date:  2009-12-18       Impact factor: 5.911

3.  Differentiation of circulating monocytes into fibroblast-like cells.

Authors:  Darrell Pilling; Richard H Gomer
Journal:  Methods Mol Biol       Date:  2012

4.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

Authors:  G A Tennent; L B Lovat; M B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

5.  Pentraxin binding to isolated rat liver nuclei.

Authors:  E G Shephard; P J Smith; S Coetzee; A F Strachan; F C de Beer
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

6.  Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.

Authors:  J Andrew Aquilina; Carol V Robinson
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

7.  Sulphatide-binding properties are shared by serum amyloid P component and a polyreactive germ-line IgM autoantibody, the TH3 idiotype.

Authors:  P R Wheeler; J G Raynes; G M O'Sullivan; D Duggan; K P McAdam
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

8.  Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.

Authors:  G C Yang; R Nieto; I Stachura; G R Gallo
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria.

Authors:  C R Hind; P M Collins; M L Baltz; M B Pepys
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

10.  Human Pentraxins Bind to Misfolded Proteins and Inhibit Production of Type I Interferon Induced by Nucleic Acid-Containing Amyloid.

Authors:  Stephanie M Dorta-Estremera; Wei Cao
Journal:  J Clin Cell Immunol       Date:  2015-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.